Euros50.2m Schleicher & Schuell deal will give Whatman 16% market share
This article was originally published in Clinica
Executive Summary
Whatman's planned purchase of Germany-based Schleicher & Schuell for £34.6m ($63.8m) will give the UK separations company a 16% share of the global lab sciences sector, making it the clear number three behind Millipore and Pall. The integration of Dassel-based S&S will increase Whatman's employee base by some 400 to over 1,110 and expand its sales by around 40%, the combined unit expecting sales in 2005 of some £116m, including £34m from S&S.
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.